Injectafer

Ferric Carboxymaltose

5.9 Moderate risk

Injectafer & Hypophosphataemia

7.7%

of users reported Hypophosphataemia

72.7%

also reported Severe reaction

57.2%

are women

Most common medical consequences

Severe reaction
72.7%
Hospitalization
18.8%
Life-threatening condition
5.8%
Disability
1.3%
Medical Intervention
1.3%

Have you experienced any negative side effects from this medication?

Injectafer: general information

Most common side effects (75)

Most commonly affected ages

10 - 19 years
2.4%
20 - 29 years
5.8%
30 - 39 years
21.5%
40 - 49 years
23.2%
50 - 59 years
17.0%
60 - 69 years
16.5%
70 - 79 years
8.8%
80 - 89 years
4.0%
90 - 99 years
0.9%